Biotech vs The Budget 2019-20 video

Last week, Treasurer Josh Frydenberg announced the Morrison government’s Budget for 2019-20, should they win the federal election in May. In a newly released video, The iQ Group Global’s Senior Economist Laurence Parker-Brown explains the crucial changes needed to activate a thriving biotech industry in Australia – and why the industry cannot rely on government […]

More

iQGG In The Australian Financial Review

Dr George Syrmalis, Group CEO and Chairman of The iQ Group Global, is featured in The Australian Financial Review today. In the interview Dr Syrmalis discusses the evolution of biotech in China, outlines The Group’s plans to enter the Chinese market with the ground-breaking biosensor platform technology, and details the strategy behind The Group’s proposed […]

More

Dr George Syrmalis featured in CEO Magazine

Dr George Syrmalis, Group CEO of The iQ Group Global, is featured in the November edition of The CEO Magazine. In his interview ‘The Power of Practical Thinking’, Dr Syrmalis discusses his approach to leadership, outlines his vision for The Group’s future, and highlights the necessity for pragmatism in the biopharmaceutical industry. The article also […]

More

Chinese patent granted for the Biosensor platform

iQnovate Ltd (NSX:IQN) The executive management of iQnovate Ltd, on behalf of its subsidiary company Life Science Biosensor Diagnostics Pty Ltd (LSBD), is pleased to announce it has been granted a key patent for its biosensor platform in the People’s Republic of China. This will enable LSBD to enjoy patent protection in China until the […]

More